98814-28-9 Usage
Description
PYRIMIDINE, 4,6-DICHLORO-5-METHYL-2-(METHYLSULFONYL)is a chemical compound that features a pyrimidine ring with two chlorine atoms at the 4 and 6 positions, a methyl group at the 5 position, and a methylsulfonyl group at the 2 position. PYRIMIDINE, 4,6-DICHLORO-5-METHYL-2-(METHYLSULFONYL)is utilized in the synthesis of various organic compounds, including pharmaceuticals and agricultural chemicals. Due to its potential biological activities and possible risks to human health and the environment, it is crucial to handle this compound with care.
Uses
Used in Pharmaceutical Industry:
PYRIMIDINE, 4,6-DICHLORO-5-METHYL-2-(METHYLSULFONYL)is used as an intermediate in the synthesis of pharmaceuticals for its potential biological activities, contributing to the development of new drugs and therapies.
Used in Agricultural Chemical Industry:
PYRIMIDINE, 4,6-DICHLORO-5-METHYL-2-(METHYLSULFONYL)is also used as a building block in the creation of agricultural chemicals, such as pesticides and herbicides, to improve crop protection and yield.
Check Digit Verification of cas no
The CAS Registry Mumber 98814-28-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,8,8,1 and 4 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 98814-28:
(7*9)+(6*8)+(5*8)+(4*1)+(3*4)+(2*2)+(1*8)=179
179 % 10 = 9
So 98814-28-9 is a valid CAS Registry Number.
98814-28-9Relevant articles and documents
HETEROARYL PIPERIDINE ETHER ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR
-
Page/Page column 57, (2018/07/29)
The present invention is directed to heteroarylpiperidine ether compounds which are allosteric modulators of the M4 muscarinic acetylcholine receptor. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which M4 muscarinic acetylcholine receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which M4 muscarinic acetylcholine receptors are involved.
